Need professional-grade analysis? Visit stockanalysis.com
$44,528
0.06
N/A
N/A
Enzon Pharmaceuticals Inc (ENZN) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $6.64, up 10.89% from the previous close.
Over the past year, ENZN has traded between a low of $0.04 and a high of $7.80. The stock has gained 7280.7% over this period. It is currently 14.8% below its 52-week high.
Enzon Pharmaceuticals Inc has a market capitalization of $44,528, with a price-to-earnings ratio of 0.06.
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Side-by-side comparison against top Healthcare peers.